Results 111 to 120 of about 17,572 (227)

Occult Hepatitis B Virus Infection in Hyperlipidemia Patients

open access: yesThe Tohoku Journal of Experimental Medicine, 2017
Chronic hepatitis B virus (HBV) infection is associated with lower prevalence of hyperlipidemia (HLP). However, occult HBV infection (OBI) in HLP patients has not yet been explored. OBI is defined as the presence of detectable HBV DNA in serum or liver tissue but undetectable HBV surface antigen in serum.
Liu, Yang   +8 more
openaire   +3 more sources

Occult Hepatitis B Virus Infection: Transmission and Reactivation

open access: yesThe Korean Journal of Gastroenterology, 2013
Occult HBV infection (OBI) is defined as presence of HBV DNA in the liver tissue in patients with serologically undetectable HBsAg. There are differences in virologic and serological profiles of OBI. Majority of OBI are positive for anti-HBs and/or anti-HBc and minor portion are negative for all HBV markers.
Sang Hee, Song, Seong Gyu, Hwang
openaire   +2 more sources

Pathogenesis of occult chronic hepatitis B virus infection

open access: yesWorld Journal of Gastroenterology, 2011
Occult hepatitis B infection (OBI) is characterized by hepatitis B virus (HBV) DNA in serum in the absence of hepatitis B surface antigen (HBsAg) presenting HBsAg-negative and anti-HBc positive serological patterns. Occult HBV status is associated in some cases with mutant viruses undetectable by HBsAg assays; but more frequently it is due to a strong ...
Rocio Aller, de la Fuente   +5 more
openaire   +2 more sources

Absence of occult hepatitis B among blood donors in southern Brazil

open access: yesBrazilian Journal of Infectious Diseases, 2011
Background: Occult hepatitis B virus (HBV) infection is characterized by the detection of HBV DNA in serum and/or in liver in the absence of detectable hepatitis B surface antigen (HBsAg).
Fernando Herz Wolff, MD, PhD.   +2 more
doaj   +1 more source

Metode Nucleic Acid Test Untuk Uji Saring Virus Hepatitis B Pada Darah Donor Dengan Hepatitis B Occult [PDF]

open access: yes, 2015
HBsAg is the primary screening at the Blood Transfusion Unit (UTD) in Indonesia. Blood with HBsAg negative still have potential to transmit the Hepatitis B Virus (HBV) infection.
Setiawaty, V. (Vivi)   +1 more
core  

Hepatitis B and Renal Disease [PDF]

open access: yes, 2010
Glomerulonephritis is an important extrahepatic manifestation of chronic hepatitis B virus (HBV) infection. The uncommon occurrence, variability in renal histopathology, and heterogeneity in clinical course present challenges in clinical studies and have
Tak Mao Chan
core   +2 more sources

Epidemiology of hepatitis C virus in Iran [PDF]

open access: yes, 2015
In Iran, the prevalence of hepatitis C virus (HCV) infection is relatively low according to the populationb a s e d e p i d e m i o l o g i c a l s t u d i e s .
Farshadpour, Fatemeh, Taherkhani, Reza
core   +2 more sources

Occult B infection in the Brazilian northeastern region: a preliminary report

open access: yesBrazilian Journal of Infectious Diseases
A sentinel study on viral hepatitis is currently being carried out in the village of Cavunge in a semiarid rural region of the state of Bahia, northeastern Brazil. This study has identified individuals in whom anti-HBc IgG was the only serological marker
Delvone Almeida   +6 more
doaj   +1 more source

Relationship between occult hepatitis B virus infection and chronic kidney disease in a Chinese population-based cohort

open access: yesChronic Diseases and Translational Medicine, 2016
Objective: Previous studies have revealed inconsistent results regarding the association between occult hepatitis B virus (HBV) infection and chronic kidney disease (CKD).
Xiang-Lei Kong   +3 more
doaj   +1 more source

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure. [PDF]

open access: yes, 2019
Hepatitis B virus (HBV) is one of the most significant hepatocarcinogens. The ultimate goal of anti-HBV treatment is to prevent the development of hepatocellular carcinoma (HCC).
Coben, Robert M.   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy